Clinical Trial Update: A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) [Phase 3]

View source ↗

Summary

A Phase 3 trial FRONTER 5 completed, evaluating the safety of switching from emicizumab to Mim8 in people with Haemophilia A, including those with inhibitors. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia
• Haemophilia with Inhibitors

Drugs mentioned

• Hemlibra (emicizumab)
• MIM8

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A, Haemophilia A With Inhibitors | Phase 3 | Status: COMPLETED